Literature DB >> 16972326

Inactivation of the tumor suppressor Krüppel-like factor 6 (KLF6) by mutation or decreased expression in hepatocellular carcinomas.

Xiu-cheng Pan1, Zhi Chen, Feng Chen, Xiao-hong Chen, Han-yin Jin, Xiao-yan Xu.   

Abstract

BACKGROUND AND AIM: The Krüppel-like transcription factor KLF6 is a novel tumor-suppressor gene. It was inactivated in human prostate cancer and other tumors tissue, as the result of frequent mutation and loss of heterozygosity (LOH). However, there is no data reporting the levels of KLF6 both mRNA and protein in hepatocellular carcinomas (HCCs). We therefore detected mutations and expression of KLF6 in HCC tissues and further observed the effect of it on cell growth in HCC cell lines.
METHODS: We analyzed the exon-2 of KLF6 gene by direct DNA sequencing, and detected the expression of KLF6 by RT-PCR and Western blot in 23 HCC tissues and corresponding nontumorous tissues. Loss of growth suppressive effect of the HCC-derived KLF6 mutant was characterized by in vitro growth curves plotted, flow cytometry and Western blotting.
RESULTS: KLF6 mutations were found in 2 of 23 HCC tissues and one of mutations was missense. Expression of KLF6 mRNA or protein was down-regulated in 8 (34.7%) or 9 (39.1%) of 23 HCC tissues. Wild-type KLF6 (wtKLF6) inhibited cellular proliferation and prolonged G1-S transition by inducing the expression of p21WAF1 following stable transfection into cultured HepG2 cells, but tumor-derived KLF6 mutant (mKLF6) had no effects.
CONCLUSION: Our findings suggest that KLF6 may be involved in pathogenesis of HCC.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16972326      PMCID: PMC1599806          DOI: 10.1631/jzus.2006.B0830

Source DB:  PubMed          Journal:  J Zhejiang Univ Sci B        ISSN: 1673-1581            Impact factor:   3.066


  21 in total

1.  KLF6 is not the major target of chromosome 10p losses in glioblastomas.

Authors:  Luisa Montanini; Lorena Bissola; Gaetano Finocchiaro
Journal:  Int J Cancer       Date:  2004-09-10       Impact factor: 7.396

2.  Absence of KLF6 gene mutations in human astrocytic tumors and cell lines.

Authors:  Pasi A Koivisto; Xiaohui Zhang; Satu-Leena Sallinen; Pauli Sallinen; Heikki J Helin; Jin-Tang Dong; Erwin G Van Meir; Hannu Haapasalo; Eija-Riitta Hyytinen
Journal:  Int J Cancer       Date:  2004-09-10       Impact factor: 7.396

3.  Absence of mutations in the putative tumor suppressor gene KLF6 in glioblastomas and meningiomas.

Authors:  Benjamin Köhler; Marietta Wolter; Britta Blaschke; Guido Reifenberger
Journal:  Int J Cancer       Date:  2004-09-10       Impact factor: 7.396

4.  A new role for the Kruppel-like transcription factor KLF6 as an inhibitor of c-Jun proto-oncoprotein function.

Authors:  Daniela A Slavin; Nicolás P Koritschoner; Claudio C Prieto; Fernando J López-Díaz; Bruno Chatton; José Luis Bocco
Journal:  Oncogene       Date:  2004-10-28       Impact factor: 9.867

Review 5.  Focus on hepatocellular carcinoma.

Authors:  Jordi Bruix; Loreto Boix; Margarita Sala; Josep M Llovet
Journal:  Cancer Cell       Date:  2004-03       Impact factor: 31.743

6.  Frequent inactivation of the tumor suppressor Kruppel-like factor 6 (KLF6) in hepatocellular carcinoma.

Authors:  Sigal Kremer-Tal; Helen L Reeves; Goutham Narla; Swan N Thung; Myron Schwartz; Analisa Difeo; Amanda Katz; Jordi Bruix; Paulette Bioulac-Sage; John A Martignetti; Scott L Friedman
Journal:  Hepatology       Date:  2004-11       Impact factor: 17.425

7.  Krüppel-like factor 6 is frequently down-regulated and induces apoptosis in non-small cell lung cancer cells.

Authors:  Genshi Ito; Mika Uchiyama; Masashi Kondo; Shoichi Mori; Noriyasu Usami; Osamu Maeda; Tsutomu Kawabe; Yoshinori Hasegawa; Kaoru Shimokata; Yoshitaka Sekido
Journal:  Cancer Res       Date:  2004-06-01       Impact factor: 12.701

8.  Cyclin-dependent kinase inhibition by the KLF6 tumor suppressor protein through interaction with cyclin D1.

Authors:  Sharon Benzeno; Goutham Narla; Jorge Allina; George Z Cheng; Helen L Reeves; Michaela S Banck; Joseph A Odin; J Alan Diehl; Doris Germain; Scott L Friedman
Journal:  Cancer Res       Date:  2004-06-01       Impact factor: 12.701

9.  KLF6, a putative tumor suppressor gene, is mutated in astrocytic gliomas.

Authors:  Yung-Ming Jeng; Hey-Chi Hsu
Journal:  Int J Cancer       Date:  2003-07-10       Impact factor: 7.396

10.  Suppression of glioblastoma tumorigenicity by the Kruppel-like transcription factor KLF6.

Authors:  Alec C Kimmelman; Rui F Qiao; Goutham Narla; Asoka Banno; Nelson Lau; Paula D Bos; Nelson Nuñez Rodriguez; Bertrand C Liang; Abhijit Guha; John A Martignetti; Scott L Friedman; Andrew M Chan
Journal:  Oncogene       Date:  2004-06-24       Impact factor: 9.867

View more
  6 in total

1.  A small interfering RNA targeting the KLF6 splice variant, KLF6-SV1, as gene therapy for gastric cancer.

Authors:  Hui Chen; Lili Chen; Lingyu Sun; Hongqun Zhen; Xiaomei Li; Qifan Zhang
Journal:  Gastric Cancer       Date:  2011-05-03       Impact factor: 7.370

2.  Decreased expression of KLF6 and its significance in gastric carcinoma.

Authors:  Qing Zhang; Xiao-ping Tan; Yue-sha Yuan; Cheng-ming Hu; Chang-hua He; Wei-zheng Wang; Jun-chuan Li; Qiu Zhao; Nan-zhi Liu
Journal:  Med Oncol       Date:  2009-12-05       Impact factor: 3.064

3.  Expression and Function of Kruppel Like-Factors (KLF) in Carcinogenesis.

Authors:  Christophe Bureau; Naima Hanoun; Jérôme Torrisani; Jean-Pierre Vinel; Louis Buscail; Pierre Cordelier
Journal:  Curr Genomics       Date:  2009-08       Impact factor: 2.236

4.  KLF6 inhibits estrogen receptor-mediated cell growth in breast cancer via a c-Src-mediated pathway.

Authors:  Jun Liu; Tian Du; Yufeng Yuan; YueMing He; Zui Tan; Zhisu Liu
Journal:  Mol Cell Biochem       Date:  2009-08-26       Impact factor: 3.396

5.  Functional role of the KLF6 tumour suppressor gene in gastric cancer.

Authors:  Jaya Sangodkar; Jiayan Shi; Analisa DiFeo; Rachel Schwartz; Romina Bromberg; Aisha Choudhri; Kim McClinch; Raheleh Hatami; Elias Scheer; Sigal Kremer-Tal; John A Martignetti; Alex Hui; W K Leung; Scott L Friedman; Goutham Narla
Journal:  Eur J Cancer       Date:  2008-12-26       Impact factor: 9.162

6.  GSK3β phosphorylation of the KLF6 tumor suppressor promotes its transactivation of p21.

Authors:  U E Lang; P Kocabayoglu; G Z Cheng; Z Ghiassi-Nejad; U Muñoz; D Vetter; D A Eckstein; R A Hannivoort; M J Walsh; S L Friedman
Journal:  Oncogene       Date:  2012-10-22       Impact factor: 9.867

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.